Latent Raises $80M Series A to Transform the Path from Diagnosis to Treatment
Latent, a clinical AI company focused on accelerating access to life-saving medications, has announced the successful close of an $80 million Series A funding round. The round was co-led by Spark Capital and Transformation Capital, with participation from Conviction, McKesson Ventures, General Catalyst, and Y Combinator.
The funding marks a significant milestone for the company as it continues to address one of the most persistent and complex challenges in healthcare: ensuring that patients receive timely treatment after diagnosis. Already working with 50% of the top 20 health systems in the United States, Latent is positioning itself as a critical player in modernizing clinical workflows and improving patient outcomes at scale.
The Growing Gap Between Diagnosis and Treatment
Despite rapid advancements in medical science and the availability of innovative therapies, the systems responsible for delivering care have struggled to keep pace. In today’s healthcare environment, the process of moving from diagnosis to treatment remains inefficient and fragmented.
In the United States, a typical patient journey involves a physician diagnosing a condition and recommending a treatment plan. However, in approximately 42% of critical cases, the prescribed life-saving medication is either delayed or denied. These delays are not due to a lack of medical knowledge or incorrect clinical decisions. Instead, they arise from systemic barriers embedded in administrative and operational processes.
Before a patient can receive therapy, the treatment must pass through multiple layers of validation. This includes clinical documentation requirements, payer approval processes, and pharmacy coordination. Each step introduces friction, increasing the likelihood of delays and, in some cases, preventing patients from receiving the care they need altogether.
A System Held Together by Manual Work
At the core of this problem lies an overreliance on manual processes. Healthcare professionals, including clinicians, administrative staff, and pharmacy teams, are required to navigate a maze of disconnected systems and workflows.
Clinicians often switch between electronic health record (EHR) systems, manually input data, and compile documentation to justify treatment decisions. Pharmacy teams frequently re-enter the same information across multiple platforms, while administrative staff spend hours communicating with insurance providers to verify coverage and secure approvals.
This work is not merely administrative—it is deeply clinical in nature. It involves interpreting lab results, applying complex treatment criteria, and aligning patient diagnoses with payer policies. Despite its importance, this high-stakes knowledge work is still performed largely by hand.
The result is a system that is both inefficient and prone to error, placing additional burden on healthcare providers and delaying critical care for patients.
Introducing the Clinical Reasoning Engine
Latent is addressing this challenge through the development of its proprietary Clinical Reasoning Engine. This AI-powered platform is designed to automate and streamline the complex processes that occur between a physician’s decision and a patient receiving treatment.
The engine performs sophisticated clinical knowledge work by analyzing patient data, interpreting drug eligibility criteria, extracting relevant clinical evidence, and coordinating workflows across multiple stakeholders. By integrating these functions into a single system, Latent aims to eliminate the fragmentation that currently defines healthcare delivery.
Unlike traditional automation tools, the Clinical Reasoning Engine is built to reason through clinical scenarios. It can understand the nuances of medical records, align them with payer requirements, and generate the necessary documentation to support treatment approval—all in real time.
Connecting the Healthcare Ecosystem
One of Latent’s key innovations lies in its ability to connect disparate components of the healthcare ecosystem. The platform integrates electronic health records, payer guidelines, pharmacy operations, and patient engagement tools into a unified framework.
This connectivity enables seamless communication and coordination among providers, insurers, pharmacies, and patients. By replacing manual processes with AI-driven workflows, Latent allows healthcare providers to move patients from diagnosis to therapy more efficiently—often within the same day.
The impact of this approach is significant. By reducing administrative friction and accelerating approvals, the platform not only improves operational efficiency but also enhances the overall patient experience.
Starting with Prior Authorization
Latent initially focused on prior authorization, one of the most challenging and time-consuming aspects of healthcare administration. Prior authorization requires providers to obtain approval from insurance companies before administering certain treatments, often involving complex clinical criteria and extensive documentation.
This process is a major source of provider burnout and can lead to delays in care, with some patients abandoning treatment altogether due to the complexity and uncertainty involved.
By tackling prior authorization, Latent demonstrated its ability to handle one of the most difficult problems in healthcare. The company developed expertise in interpreting drug criteria, analyzing medical records, and generating accurate, compliant documentation—capabilities that form the foundation of its broader platform.
Having proven success in this area, Latent is now expanding its technology to address additional processes where clinical knowledge must be translated into actionable steps.
Rapid Growth and Measurable Impact
Latent’s growth over the past year has been remarkable. The company has expanded its network from just four health system partners to more than 45, now serving half of the top 20 health systems in the United States.
Through its platform, more than 2 million patients each year are gaining faster access to critical medications. Across a wide range of specialties and therapeutic areas, Latent has delivered measurable improvements in healthcare delivery.
Key outcomes include:
- A reduction in treatment denials by more than 30%
- Increased efficiency, enabling clinicians to serve up to twice as many patients
- Faster turnaround times for therapy approvals and initiation
These results highlight the transformative potential of AI in addressing long-standing inefficiencies in healthcare systems.
A Vision for Proactive Care
Looking ahead, Latent aims to move beyond reactive processes and into proactive care management. The company envisions a future where its Clinical Reasoning Engine can identify patients who would benefit from specific therapies even before a formal treatment decision is made.
By analyzing patient data in real time, the platform could flag opportunities for early intervention, ensuring that patients begin treatment at the optimal time. Additionally, it could help monitor adherence, ensuring that patients remain on their prescribed therapies and achieve the best possible outcomes.
This proactive approach has the potential to significantly improve population health while reducing costs associated with delayed or incomplete treatment.
Building the Infrastructure for Modern Healthcare
Latent’s broader mission is to create the infrastructure that connects clinicians, patients, and payers in a seamless and intelligent ecosystem. By powering the knowledge work that determines what care patients ultimately receive, the company is redefining how healthcare is delivered.
The Clinical Reasoning Engine serves as the backbone of this vision, enabling real-time decision-making and coordination across the entire care continuum. As the platform evolves, it will continue to expand its capabilities, addressing additional areas of complexity within the healthcare system.
Scaling with New Funding
The $80 million Series A funding will play a crucial role in advancing Latent’s mission. The company plans to use the capital to expand its footprint across additional health systems, deepen integrations with key stakeholders, and enhance the reliability and trustworthiness of its platform.
Investments will also be directed toward scaling the team, attracting top talent committed to transforming healthcare delivery. Latent emphasizes a culture rooted in responsibility, where the goal extends beyond diagnosis to ensuring that patients actually receive the care they need.
Redefining Responsibility in Healthcare
At its core, Latent is driven by a simple yet powerful belief: responsibility in healthcare does not end with diagnosis. Ensuring that patients receive timely and effective treatment is an equally critical part of the care journey.
By addressing the systemic barriers that prevent access to therapy, Latent is helping to close the gap between medical innovation and real-world outcomes. Its AI-driven approach represents a fundamental shift in how healthcare systems operate—moving from fragmented, manual processes to integrated, intelligent workflows.
As the company continues to grow, it is poised to play a central role in shaping the future of healthcare, where life-saving treatments are not just available, but accessible to every patient who needs them.
About Latent Health
Latent Health is the leading AI platform for medication access. The company brings clinical intelligence directly into the patient record, helping care teams move patients from clinical decision to therapy faster and more reliably. Latent is helping more than 2 million patients annually and is trusted by more than 45 of the nation’s leading health systems, including Yale New Haven Health, Ochsner Health, MetroHealth, UCI, Vanderbilt Health, Mount Sinai Health System, Henry Ford Health System, UCSF Health, and UCLA Health. Founded by Sriram Somasundaram and Rishabh Jain, Latent has raised $80M in total funding from Transformation Capital, Spark Capital, McKesson Ventures, Conviction, General Catalyst, Y Combinator, and others.
